Crominex®‐3+ is a Chromium III‐polyphenolic complex, which is a safer form of Chromium. Crominex‐3+ comes as a fine powder with a 2% concentration of Chromium which results in greater content uniformity in the finished capsules or tablets.
One published clinical study with Crominex®‐3+ in adjuvant therapy with prescription oral antidiabetic drugs in type 2 diabetics has shown that it can reduce blood glucose levels, especially post‐prandial. Two additional human clinical studies – one in type 2 diabetics and the other in subjects with metabolic syndrome symptoms – have shown that Crominex‐3+ improves endothelial function as well as cardiovascular health. A study in arthritic dogs at Murray State University in Kentucky has shown that Crominex‐3+ has significantly improved arthritic conditions in dogs.